title: [Drug combinations of lithium: reasons and limitations].
abstract: Lithium is widely used in the treatment of several psychiatric diseases-bipolar mood disorder, in particular. It is often necessary to have lithium combined with other psychopharmacological agents when efforts are aimed at either enhancing a less-than-optimal therapeutic effect or treating other symptoms as well. A therapist should be familiar with every possibility, limitation, and probable risk such pharmacological combinations are likely to lead to.
authors.affiliation: Fundación de Bipolares de la Argentina, Buenos Aires, Argentina.
authors.forename: A J
authors.initials: AJ
authors.lastname: Lagomarsino
mesh_terms: D000928:Antidepressive Agents / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy*; D002220:Carbamazepine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008094:Lithium / Q000627:therapeutic use*; D008297:Male; D014635:Valproic Acid / Q000627:therapeutic use
chemical_list: D000928:Antidepressive Agents; D002220:Carbamazepine; D014635:Valproic Acid; D008094:Lithium
vernacular_title: Las asociaciones medicamentosas del litio: para qué y con qué cuidados?